FIELD: physics.
SUBSTANCE: group of inventions belongs to the field of energetic compounds, and in particular relates to variants of compounds having a crystal structure of the ABX3 perovskite type, which can be used as an energetic material. Component A in the compound according to the first embodiment is at least one divalent cation of a nitrogen-containing organic compound; component B in the compound is NH4+; component X in the compound is at least one monovalent anion selected from ClO4-, BrO4-, IO4-, ONC-, NO3- and N (NO2)2-. The compound having a crystal structure of the ABX3 perovskite type according to the second embodiment is obtained by adding component A, component B and component X to the liquid reaction system in any order for the reaction. Component A is a nitrogen-containing organic compound capable of forming a divalent cation in the liquid reaction system; component B contains a cation and the cation is NH4 +; component X is at least one compound selected from acids or salts containing an anion selected from ClO4-, BrO4-, IO4-, ONC-, NO3- and N (NO2)2-. The structural characteristics of the perovskite type allow this type of compound to be highly stable, thus overcoming the insecurity of an explosive having poor stability in the prior art. At the same time, the structural characteristics of the compound, such as rich energy ligands as well as alternating oxidative energy anions and reductive organic cations in space, provide the compound with excellent instant energy release efficiency upon detonation.
EFFECT: resulting three-dimensional structure allows the compound not only to have an energetic material effect, but also to overcome the disadvantages of some existing energetic materials.
31 cl, 25 dwg, 18 tbl
Title | Year | Author | Number |
---|---|---|---|
USE OF COMPOUNDS AS ENERGY MATERIALS | 2017 |
|
RU2725424C2 |
COMPOUND AND METHOD FOR PREPARATION AND USE THEREOF AS ENERGY MATERIALS | 2021 |
|
RU2825338C1 |
POLYMORPHIC AND PSEUDOPOLYMORPHIC FORMS OF PHARMACEUTICAL COMPOUND | 2010 |
|
RU2575173C2 |
POLYMORPHOUS AND PSEUDOPOLYMORPHOUS FORMS OF THE PHARMACEUTICAL COMPOUND | 2010 |
|
RU2727509C2 |
OPTICALLY ACTIVE DIAZABICYCLOOCTANE DERIVATIVE AND METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2591701C2 |
CRYSTALLINE FORMS OF THE TLR7/TLR8 INHIBITOR | 2019 |
|
RU2792005C2 |
CHEMICAL METHOD | 2013 |
|
RU2644160C2 |
METHOD FOR PRODUCTION OF 7H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THEIR COCRYSTALS | 2017 |
|
RU2779212C2 |
CRYSTALLINE PYRIMIDINYL-3,8-DIAZABICYCLO[3.2.1]OCTANYLMETHANONE AND ITS APPLICATIONS | 2020 |
|
RU2803145C2 |
CRYSTALLINE FORMS OF DIAZABICLOCTANE DERIVATIVE AND A METHOD OF THEIR PRODUCTION | 2014 |
|
RU2801220C2 |
Authors
Dates
2021-07-22—Published
2017-08-11—Filed